Clinical Trials Browser

Phase 1/2 × Dactinomycin × Dermatologic × Clear all

NCT01531244 2014-07-18

Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma

Phase 1/2 Withdrawn

Melanoma